ACB NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Aurora Cannabis Inc · Healthcare · Drug Manufacturers - Specialty & Generic

Latest close 2.79 USD
4.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -17.9% below the Trend Line and sits at 5.6% of its 52-week range. The latest completed week returned 4.5%, after a -1.8% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 3d.

Setup score 19 out of 100
Latest Close 2.79 USD 31 Jul 2026
1W Return 4.5% latest completed week
4W Return -1.8% short-term follow-through
12W Return -18.2% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -17.9% below the Trend Line and sits at 5.6% of its 52-week range. The latest completed week returned 4.5%, after a -1.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0212-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.8% over four weeks, -18.2% over 12 weeks, and -37.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W4.5%
4W-1.8%
12W-18.2%
26W-31.3%
52W-37.7%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.98Latest activity-pressure read.
Pressure change-255.2%Four-week change in activity pressure.
Leadership-37.46Latest relative-leadership reading.
RS change9.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength48/100Blend of value, momentum, and quality. Underlying universe rank 53; rank 1 is best.
Value87/100Relative valuation strength. Underlying universe rank 14; rank 1 is best.
Quality12/100Profitability and accounting quality. Underlying universe rank 89; rank 1 is best.
Momentum7/100Medium-term price momentum. Underlying universe rank 94; rank 1 is best.
Growth18/100Revenue and earnings growth. Underlying universe rank 83; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
56.6%
Gross profit retained from each unit of revenue.
Operating margin
-9.4%
Operating profit retained from revenue.
Free-cash-flow margin
2.9%
Free cash flow generated from revenue.
Return on invested capital
-5.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-9.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-74.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-6.6%
Net share repurchases relative to market value.
Shareholder yield
-6.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
5.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

ACB shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.02, expected move of 16.1%, and Sharemaestro trend signal inactive.

Conviction52/100
Expected move16.1%
Put/call volume0.02
Pressure100
Speculation1
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 58 relevant articles.

23 positive · 31 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move16.1%Nearest-chain priced movement where available.
52-week drawdown-58.1%Distance below the 52-week high.
13-week volatility4.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+7.5%Week of 3 Apr.
Worst week-14.3%Week of 6 Feb.
Latest week+4.5%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains5
Flat weeks0
Modest losses8
Sharp losses7
Recent vol4.2%13-week weekly-return volatility.
Base vol6.6%52-week weekly-return volatility.
Up/down split19/30Count of positive and negative weeks in the 52-week window.
Average skew6.1% / -5.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.79 USD4.5%3.40 USD4.75 USD-0.98-37.466.0MOff
24 Jul 20262.67 USD1.5%3.45 USD4.77 USD-1.00-40.535.5MOff
17 Jul 20262.63 USD-3.0%3.51 USD4.78 USD-0.80-43.145.6MOff
10 Jul 20262.71 USD-4.6%3.59 USD4.80 USD-0.55-44.546.3MOff
3 Jul 20262.84 USD0.4%3.68 USD4.82 USD-0.28-41.564.8MOff
26 Jun 20262.83 USD-3.4%3.74 USD4.83 USD-0.09-41.955.9MOff
19 Jun 20262.93 USD-3.6%3.80 USD4.85 USD0.13-43.176.0MOff
12 Jun 20263.04 USD-10.1%3.84 USD4.87 USD0.27-40.106.5MOff
5 Jun 20263.38 USD-6.1%3.88 USD4.88 USD0.32-33.133.2MOff
29 May 20263.60 USD4.0%3.92 USD4.89 USD0.27-33.072.5MOff
22 May 20263.46 USD4.2%3.97 USD4.90 USD0.13-34.733.1MOff
15 May 20263.32 USD-2.6%4.03 USD4.92 USD0.04-37.593.4MOff
8 May 20263.41 USD-2.0%4.09 USD4.94 USD-0.09-36.943.7MOff
1 May 20263.48 USD2.7%4.15 USD4.95 USD-0.37-32.995.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.